Revolutionary Technology Improves Lives of Children with Type 1 Diabetes in England

Around 20,000 children and young people in England are now reaping the benefits of an innovative technology known as the 'artificial pancreas,' a hybrid closed loop (HCL) system recommended by the National Institute for Health and Care Excellence (NICE). This cutting-edge technology has been instrumental in enhancing blood sugar control for those managing type 1 diabetes, thus dramatically transforming daily life for the families affected by this complex condition.
Following NICE's recommendation in December 2023, the uptake of hybrid closed loop systems surged impressively, increasing from just over one-third to nearly two-thirds of eligible candidates within a single year. According to the latest data from the
James Whitmore










